CEO of Therapeuticsmd Inc (30-Year Financial, Insider Trades) Robert G Finizio (insider trades) bought 52,405 shares of TXMD on 08/09/2019 at an average price of $2.96 a share. The total cost of this purchase was $155,119.
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product. TherapeuticsMD Inc has a market cap of $716.420 million; its shares were traded at around $2.97 with and P/S ratio of 38.57. TherapeuticsMD Inc had annual average EBITDA growth of 30.00% over the past ten years. GuruFocus has detected 6 severe warning signs with TherapeuticsMD Inc. .
CEO Recent Trades:
- CEO Robert G Finizio bought 52,405 shares of TXMD stock on 08/09/2019 at the average price of $2.96. The price of the stock has increased by 0.34% since.
For the complete insider trading history of TXMD, click here
.This article first appeared on GuruFocus.
- Warning! GuruFocus has detected 7 Warning Signs with TXMD. Click here to check it out.
- TXMD 15-Year Financial Data
- The intrinsic value of TXMD
- Peter Lynch Chart of TXMD